Screening for transient biological interactions as applied to albumin ligands: a new concept for drug discovery
- PMID: 17052679
- DOI: 10.1016/j.ab.2006.09.007
Screening for transient biological interactions as applied to albumin ligands: a new concept for drug discovery
Abstract
The notion that many biological interactions are based on transient binding (dissociation constants (K(d)) in the range of 10-0.01 mM) is familiar, yet the implications for biological sciences have been realized only recently. An important area of biological sciences is drug design, where the traditional "lock and key" view of binding has prevailed and drug candidates are usually selected on their merits as being tight binders. However, the rationale that transient interactions are of importance for drug discovery is slowly gaining acceptance. These interactions may relate not only to the desired target interaction but also to unwanted interactions creating, for example, toxicity problems. Here we demonstrate, in a high-throughput screening format, affinity selection of weak binders to a model target of albumin by zonal retardation chromatography. It is perceived that this approach can define the "transient drug" as a complement to current drug discovery procedures.
Similar articles
-
Frontal affinity chromatography with MS detection (FAC-MS) in drug discovery.Drug Discov Today. 2005 Mar 15;10(6):409-16. doi: 10.1016/S1359-6446(04)03360-4. Drug Discov Today. 2005. PMID: 15808820 Review.
-
Designing transient binding drugs: a new concept for drug discovery.Drug Discov Today. 2008 May;13(9-10):433-9. doi: 10.1016/j.drudis.2008.02.001. Epub 2008 Mar 18. Drug Discov Today. 2008. PMID: 18468561 Review.
-
Affinity selection-mass spectrometry screening techniques for small molecule drug discovery.Curr Opin Chem Biol. 2007 Oct;11(5):518-26. doi: 10.1016/j.cbpa.2007.07.011. Epub 2007 Oct 10. Curr Opin Chem Biol. 2007. PMID: 17931956 Review.
-
A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound-target interactions.J Mol Recognit. 2005 Jul-Aug;18(4):273-81. doi: 10.1002/jmr.744. J Mol Recognit. 2005. PMID: 15997470 Review.
-
Toward high-throughput drug screening on a chip-based parallel affinity separation platform.J Sep Sci. 2010 Sep;33(17-18):2575-81. doi: 10.1002/jssc.201000314. J Sep Sci. 2010. PMID: 20730836
Cited by
-
Measurement of drug-protein dissociation rates by high-performance affinity chromatography and peak profiling.Anal Chem. 2009 Jun 1;81(11):4320-33. doi: 10.1021/ac9000404. Anal Chem. 2009. PMID: 19422253 Free PMC article.
-
Analysis of Biological Interactions by Affinity Chromatography: Clinical and Pharmaceutical Applications.Clin Chem. 2017 Jun;63(6):1083-1093. doi: 10.1373/clinchem.2016.262253. Epub 2017 Apr 10. Clin Chem. 2017. PMID: 28396561 Free PMC article. Review.
-
Analysis of drug-protein binding by ultrafast affinity chromatography using immobilized human serum albumin.J Chromatogr A. 2010 Apr 23;1217(17):2796-803. doi: 10.1016/j.chroma.2010.02.026. Epub 2010 Feb 23. J Chromatogr A. 2010. PMID: 20227701 Free PMC article.
-
Pharmaceutical modulation of the proteolytic profile of Transforming Growth Factor Beta induced protein (TGFBIp) offers a new avenue for treatment of TGFBI-corneal dystrophy.J Adv Res. 2020 May 22;24:529-543. doi: 10.1016/j.jare.2020.05.012. eCollection 2020 Jul. J Adv Res. 2020. PMID: 32637173 Free PMC article.
-
Analysis of biomolecular interactions using affinity microcolumns: a review.J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Oct 1;968:49-63. doi: 10.1016/j.jchromb.2014.01.026. Epub 2014 Jan 27. J Chromatogr B Analyt Technol Biomed Life Sci. 2014. PMID: 24572459 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources